Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/36138| Title: | Efficacy and safety of ocrelizumab in patients with RRMS with suboptimal response to prior disease-modifying therapies: 3-year data from CASTING and LIBERTO 1-year interim results | Authors: | VAN WIJMEERSCH, Bart Comi, G. Oreja-Guevara, C. Wiendl, H. Wuerfel, J. Buffels, R. Dirks, P. Kuenzel, T. Kadner, K. Vermersch, P. |
Issue Date: | 2021 | Publisher: | SAGE PUBLICATIONS LTD | Source: | MULTIPLE SCLEROSIS JOURNAL, 27 (2_SUPPL) , p. 543 -544 | Document URI: | http://hdl.handle.net/1942/36138 | e-ISSN: | 2055-2173 | ISI #: | WOS:000706771302003 | Category: | M | Type: | Journal Contribution |
| Appears in Collections: | Research publications |
Show full item record
WEB OF SCIENCETM
Citations
1
checked on Apr 24, 2024
Page view(s)
50
checked on Aug 1, 2023
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.